Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 489 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Ophthalmic Surgery Clear all

Conditions: Cataract
Interventions: Dexamethasone, Prednisolone Acetate Ophthalmic; Drug
Lead sponsor: EyePoint Pharmaceuticals, Inc.; Industry
Eligibility: Up to 3 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 9
States / cities: Huntington Beach, California • Palo Alto, California • Boston, Massachusetts + 6 more

Conditions: Open Angle Glaucoma (OAG), Ocular Hypertension (OHT)
Interventions: iDose TR (travoprost intracameral implant) 75 µg; Combination Product
Lead sponsor: Glaukos Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Inflammation
Interventions: Difluprednate, Placebo; Drug
Lead sponsor: Sirion Therapeutics, Inc.; Industry
Eligibility: 2 Years and older
Enrollment: 219 participants
U.S. locations: 1
States / cities: Washington, Missouri

Conditions: Cataract
Interventions: Vitrax II, Viscoat; Device
Lead sponsor: Abbott Medical Optics; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Santa Ana, California

Conditions: Cataract
Interventions: CALLISTO eye, Wavetec AnalyzOR; Device
Lead sponsor: Chesapeake Eyecare and Laser Center, LLC; Other
Eligibility: 55 Years to 87 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Annapolis, Maryland

Conditions: Cataracts
Interventions: Xibrom, and Optive, Xibrom and Pred Forte; Drug
Lead sponsor: Bp Consulting, Inc; Network
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Tarpon Springs, Florida

Conditions: Cataract, Presbyopia
Interventions: Neutral Aspheric Monofocal IOL, Negative Aspheric Monofocal IOL; Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 95 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Cataract
Interventions: Tecnis MF, ReSTOR; Device
Lead sponsor: Innovative Medical; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Miami, Florida • Sarasota, Florida

Conditions: Inflammation and Pain Associated With Cataract Surgery
Interventions: ISV-305, Vehicle; Drug · Other
Lead sponsor: Sun Pharmaceutical Industries Limited; Industry
Eligibility: 17 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Vitreoretinal Surgery, Ocular Inflammation, Post-operative Pain, Post-Operative Inflammation
Interventions: Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cataract, Multifocal Intraocular Lens
Interventions: Clareon PanOptix Pro and Clareon Vivity Intraocular Lens, Clareon PanOptix Pro Intraocular Lenses; Device
Lead sponsor: Brian Shafer; Other
Eligibility: 18 Years and older
Enrollment: 346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Baltimore, Maryland • Alexandria, Minnesota • Bozeman, Montana + 2 more

Conditions: Macular Edema, Epiretinal Membrane
Interventions: Not listed
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Cataract
Interventions: Bromfenac, Placebo; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Irvine, California

Conditions: Tomography
Interventions: UNITY DX, ANTERION; Device
Lead sponsor: Alcon Research; Industry
Eligibility: 22 Years and older
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Cataract, Inflammation, Surgery
Interventions: Mapracorat, Placebo; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 369 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Dry Eye Syndromes
Interventions: Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate; Drug
Lead sponsor: Sight Medical Doctors PLLC; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Brentwood, New York

Conditions: Glaucoma
Interventions: Baerveldt implant, Trabeculectomy with mitomycin C; Procedure
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 85 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2009
U.S. locations: 16
States / cities: La Jolla, California • Los Angeles, California • Sacramento, California + 13 more

Conditions: Myopia, Astigmatism
Interventions: Visumax spherocylindrical treatment; Device
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 22 Years and older
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Glaucoma
Interventions: Rho-Kinase Inhibitor (AR-12286); Drug
Lead sponsor: New York Glaucoma Research Institute; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Thyroid Eye Disease (TED), Graves Ophthalmopathy, Thyroid Associated Ophthalmopathies
Interventions: Smartphone-based AI self-monitoring application (Glandy CAS/EXO/LID); Device
Lead sponsor: THYROSCOPE INC.; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Jose, California

Conditions: Cataract
Interventions: Clobetasol propionate, Vehicle; Drug
Lead sponsor: Salvat; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 22
States / cities: Chandler, Arizona • Beverly Hills, California • Glendora, California + 19 more

Conditions: Post Ocular Surgical Inflammation and Pain
Interventions: Dexamethasone, Punctum Plug; Drug
Lead sponsor: Ocular Therapeutix, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 247 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Ocular Inflammation
Interventions: Loteprednol Etabonate, Vehicle of Ophthalmic Loteprednol Etabonate; Drug
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Antibiotic Side Effect, Eyelid; Wound, Eyelid Diseases, Surgical Wound Infection, Surgical Wound, Recent, Surgical Incision, Skin Cancer Face, Antibiotic Allergy, Surgical Site Infection
Interventions: Topical Antibiotic Product, Topical Non-Antibiotic Ointment; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 401 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract

iDose TR Administration in an Office-Based Surgery Setting

Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002b)

Clinical Evaluation of a New Viscoelastic for Cataract Surgery

Evaluate Performance of Callisto Eye vs. Wavetec AnalyzOR

Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care

MULTICENTER, DOUBLE-ARM, PATIENT AND ASSESSOR-MASKED, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL TO COMPARE VISUAL PERFORMANCE OF NEGATIVE AND NEUTRAL ASPHERIC MONOFOCAL INTRAOCULAR LENSES

Evaluation Of Bilateral Tecnis Multifocal Versus ReSTOR 3D Intraocular Lenses

Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery

Dextenza in the Post-op Management of Vitreoretinal Surgeries

Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix Pro

Epiretinal Membrane and Pseudophakic Cystoid Macular Edema

Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery

UNITY DX Cornea Study

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL

Tube Versus Trabeculectomy (TVT) Study

SMILE (Small Incision Lenticule Extraction) in the DoD (Department of Defense)

A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention

Prospective Observational Study of Smartphone-Based AI Self-Monitoring During Non-Surgical Treatment for Thyroid Eye Disease (THYROSCOPE)

Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)

Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

Topical Antibiotic Prophylaxis for Eyelids